Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor Scintigraphy

ObjectiveThe objective of this study was to evaluate the diagnostic efficacy of Pixon-based reconstruction method on planar somatostatin receptor scintigraphy (SRS).MethodsAll patients with neuroendocrine tumors (NETs) disease who were referred for SRS to our department during 1-year period from Jan...

Full description

Bibliographic Details
Main Authors: Philippe Thuillier, David Bourhis, Philippe Robin, Nathalie Keromnes, Ulrike Schick, Pierre-Yves Le Roux, Véronique Kerlan, Philippe Chaumet-Riffaud, Pierre-Yves Salaün, Ronan Abgral
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Medicine
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmed.2017.00143/full
id doaj-d60e9b4f7c7f4c5aa59564393b758a7a
record_format Article
spelling doaj-d60e9b4f7c7f4c5aa59564393b758a7a2020-11-24T22:35:01ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2017-08-01410.3389/fmed.2017.00143267017Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor ScintigraphyPhilippe Thuillier0David Bourhis1David Bourhis2Philippe Robin3Philippe Robin4Nathalie Keromnes5Nathalie Keromnes6Ulrike Schick7Pierre-Yves Le Roux8Pierre-Yves Le Roux9Véronique Kerlan10Véronique Kerlan11Philippe Chaumet-Riffaud12Pierre-Yves Salaün13Pierre-Yves Salaün14Ronan Abgral15Ronan Abgral16Department of Endocrinology, University Hospital of Brest, Brest, FranceDepartment of Nuclear Medicine, University Hospital of Brest, Brest, FranceEA GETBO 3878, IFR 148, University Hospital of Brest, Brest, FranceDepartment of Nuclear Medicine, University Hospital of Brest, Brest, FranceEA GETBO 3878, IFR 148, University Hospital of Brest, Brest, FranceDepartment of Nuclear Medicine, University Hospital of Brest, Brest, FranceEA GETBO 3878, IFR 148, University Hospital of Brest, Brest, FranceDepartment of Oncology-Radiotherapy, University Hospital of Brest, Brest, FranceDepartment of Nuclear Medicine, University Hospital of Brest, Brest, FranceEA GETBO 3878, IFR 148, University Hospital of Brest, Brest, FranceDepartment of Endocrinology, University Hospital of Brest, Brest, FranceEA GETBO 3878, IFR 148, University Hospital of Brest, Brest, FranceDepartment of Nuclear Medicine, University Hospital of Paris-Sud Bicêtre, Le Kremlin-Bicêtre, FranceDepartment of Nuclear Medicine, University Hospital of Brest, Brest, FranceEA GETBO 3878, IFR 148, University Hospital of Brest, Brest, FranceDepartment of Nuclear Medicine, University Hospital of Brest, Brest, FranceEA GETBO 3878, IFR 148, University Hospital of Brest, Brest, FranceObjectiveThe objective of this study was to evaluate the diagnostic efficacy of Pixon-based reconstruction method on planar somatostatin receptor scintigraphy (SRS).MethodsAll patients with neuroendocrine tumors (NETs) disease who were referred for SRS to our department during 1-year period from January to December 2015 were consecutively included. Three nuclear physicians independently reviewed all the data sets of images which included conventional images (CI; 15 min/view) and processed images (PI) obtained by reconstructing the first 450 s extracted data using Oncoflash® software package. Image analysis using a 3-point rating scale for abnormal uptake of 111 Indium-DTPA-Phe-octreotide in any lesion or organ was interpreted as positive, uncertain, or negative for the evidence of NET disease. A maximum grade uptake of the radiotracer in the lesion was assessed by the Krenning scale method. The results of image interpretation by the two methods were considered significantly discordant when the difference in organ involvement assessment was negative vs. positive or in lesion uptake was ≥2 grades. Agreement between the results of two methods and by different scan observers was evaluated using Cohen κ coefficients.ResultsThere was no significant (p = 0.403) correlation between data acquisition protocol and quality image. The rates of significant discrepancies for exam interpretation and organs involvement assessment were 2.8 and 2.6%, respectively. Mean κ values revealed a good agreement for concordance between CI and PI interpretation without difference of agreement for inter/intra-observer analysis.ConclusionOur results suggest the feasibility to use a Pixon-based reconstruction method for SRS planar images allowing a twofold reduction of acquisition time and without significant alteration of image quality or on image interpretation.http://journal.frontiersin.org/article/10.3389/fmed.2017.00143/fullsignal and image processingPixon-based methodsomatostatin receptor scintigraphyplanar imageshalf time acquisition
collection DOAJ
language English
format Article
sources DOAJ
author Philippe Thuillier
David Bourhis
David Bourhis
Philippe Robin
Philippe Robin
Nathalie Keromnes
Nathalie Keromnes
Ulrike Schick
Pierre-Yves Le Roux
Pierre-Yves Le Roux
Véronique Kerlan
Véronique Kerlan
Philippe Chaumet-Riffaud
Pierre-Yves Salaün
Pierre-Yves Salaün
Ronan Abgral
Ronan Abgral
spellingShingle Philippe Thuillier
David Bourhis
David Bourhis
Philippe Robin
Philippe Robin
Nathalie Keromnes
Nathalie Keromnes
Ulrike Schick
Pierre-Yves Le Roux
Pierre-Yves Le Roux
Véronique Kerlan
Véronique Kerlan
Philippe Chaumet-Riffaud
Pierre-Yves Salaün
Pierre-Yves Salaün
Ronan Abgral
Ronan Abgral
Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor Scintigraphy
Frontiers in Medicine
signal and image processing
Pixon-based method
somatostatin receptor scintigraphy
planar images
half time acquisition
author_facet Philippe Thuillier
David Bourhis
David Bourhis
Philippe Robin
Philippe Robin
Nathalie Keromnes
Nathalie Keromnes
Ulrike Schick
Pierre-Yves Le Roux
Pierre-Yves Le Roux
Véronique Kerlan
Véronique Kerlan
Philippe Chaumet-Riffaud
Pierre-Yves Salaün
Pierre-Yves Salaün
Ronan Abgral
Ronan Abgral
author_sort Philippe Thuillier
title Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor Scintigraphy
title_short Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor Scintigraphy
title_full Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor Scintigraphy
title_fullStr Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor Scintigraphy
title_full_unstemmed Clinical Validation of a Pixon-Based Reconstruction Method Allowing a Twofold Reduction in Planar Images Time of 111In-Pentetreotide Somatostatin Receptor Scintigraphy
title_sort clinical validation of a pixon-based reconstruction method allowing a twofold reduction in planar images time of 111in-pentetreotide somatostatin receptor scintigraphy
publisher Frontiers Media S.A.
series Frontiers in Medicine
issn 2296-858X
publishDate 2017-08-01
description ObjectiveThe objective of this study was to evaluate the diagnostic efficacy of Pixon-based reconstruction method on planar somatostatin receptor scintigraphy (SRS).MethodsAll patients with neuroendocrine tumors (NETs) disease who were referred for SRS to our department during 1-year period from January to December 2015 were consecutively included. Three nuclear physicians independently reviewed all the data sets of images which included conventional images (CI; 15 min/view) and processed images (PI) obtained by reconstructing the first 450 s extracted data using Oncoflash® software package. Image analysis using a 3-point rating scale for abnormal uptake of 111 Indium-DTPA-Phe-octreotide in any lesion or organ was interpreted as positive, uncertain, or negative for the evidence of NET disease. A maximum grade uptake of the radiotracer in the lesion was assessed by the Krenning scale method. The results of image interpretation by the two methods were considered significantly discordant when the difference in organ involvement assessment was negative vs. positive or in lesion uptake was ≥2 grades. Agreement between the results of two methods and by different scan observers was evaluated using Cohen κ coefficients.ResultsThere was no significant (p = 0.403) correlation between data acquisition protocol and quality image. The rates of significant discrepancies for exam interpretation and organs involvement assessment were 2.8 and 2.6%, respectively. Mean κ values revealed a good agreement for concordance between CI and PI interpretation without difference of agreement for inter/intra-observer analysis.ConclusionOur results suggest the feasibility to use a Pixon-based reconstruction method for SRS planar images allowing a twofold reduction of acquisition time and without significant alteration of image quality or on image interpretation.
topic signal and image processing
Pixon-based method
somatostatin receptor scintigraphy
planar images
half time acquisition
url http://journal.frontiersin.org/article/10.3389/fmed.2017.00143/full
work_keys_str_mv AT philippethuillier clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT davidbourhis clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT davidbourhis clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT philipperobin clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT philipperobin clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT nathaliekeromnes clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT nathaliekeromnes clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT ulrikeschick clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT pierreyvesleroux clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT pierreyvesleroux clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT veroniquekerlan clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT veroniquekerlan clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT philippechaumetriffaud clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT pierreyvessalaun clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT pierreyvessalaun clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT ronanabgral clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
AT ronanabgral clinicalvalidationofapixonbasedreconstructionmethodallowingatwofoldreductioninplanarimagestimeof111inpentetreotidesomatostatinreceptorscintigraphy
_version_ 1725725148417359872